One study indicates that SPP1 activates JNK signaling through a CD44v6-dependent pathway to promote clonogenicity of colorectal cancer cells, and the CD44v6 antibody is able to potently block the activation of JNK induced by SPP1 (Rao et al., 2013). This evidence concerns the gene MAPK8 and colorectal cancer.